Future Tech Ventures Backs SPCTR to Bring Real-Time AI to Cancer Surgery!
Future Tech Ventures has invested in SPCTR, which is developing real-time AI tools to support surgeons during oncological operations.
Precision in cancer surgery is critically important, not just to remove the tumor, but to make sure cancerous tissue is fully excised while sparing healthy tissue. Traditionally, this “margin analysis” happens hours or even days after surgery, once pathology reports return. SPCTR aims to change that by bringing real-time AI-driven margin analysis directly into the operating room, helping surgeons make better decisions while the patient is still in surgery.
The investment from Future Tech Ventures supports SPCTR in advancing its technology and scaling its impact. By combining advanced AI with surgical workflows, this innovation could reduce the need for follow-up surgeries, improve patient outcomes, and accelerate how AI is deployed in clinical practice.
This is a great example of how Dutch startups at the intersection of AI and healthcare are attracting venture capital and pushing the boundaries of what’s possible in medical technology and it highlights the strength of the Netherlands as a hub for real-world AI innovation in life sciences.
Congratulations from UtrechtInc!
👉 Read the article : https://futuretechventures.nl/update/ai-in-de-operatiekamer-future-tech-ventures-investeert-in-spctr-voor-real-time-marge-analyse-bij-oncologische-chirurgie/